Skip to content

Invest1 publisherNot yet confirmed elsewhere3 min readPublished Updated

Seized Wegovy parcels outnumber licensed shipments nine to one in Korea's customs data

Korea's grey channel for weight-loss drugs now dwarfs the licensed one by case count, and a foreign web price that domestic prescriptions cannot match is doing the work.

The Investor · Invest desk

How we use AISend a correction

Photograph accompanying Seized Wegovy parcels outnumber licensed shipments nine to one in Korea's customs data
Photo: en.sedaily.com

What happened

  • Korean customs caught 4,155 illegal personal imports of Wegovy and Mounjaro in the first half of this year, 3.5 times the 1,189 cases logged in all of last year.
  • Over the same 2024-to-June window, 596 shipments cleared customs through licensed importers, 391 of them in the first half.
  • International mail carries the trade: 3,489 cases in the first half, and 84.8 percent of all cases since 2024.
  • Customs and sedaily both attribute the surge to foreign website prices sitting below the cost of a domestic prescription.
  • Both drugs are classed as harmful drugs, so customs blocks every quantity and destroys what it holds at clearance.

Compiled by The InvestorSomething wrong?How this is made

Why it matters

  • constraint The harmful-drug designation leaves no personal-use quantity to shelter in, so a buyer who wants the foreign price has no compliant route to it and becomes an offender by definition.
  • cost Interception costs the buyer the whole purchase, not a fee, and volumes rose regardless, which prices the risk of being stopped below the saving on a domestic script.
  • exposure The hand-carry route grew nearly fivefold, and unlike a parcel it puts an identifiable traveller in front of an inspector rather than an anonymous package in a mailbag.
  • precedent The stated answer is more blocking at the border, which leaves the domestic price untouched and makes seizure counts a measure of postal screening capacity rather than of demand.

The ratio buried in the customs numbers is wider than the raw case counts get credit for. Cumulative seizures against cumulative licensed clearances is close to nine to one [14]. Take only the first half of this year and it is about eleven to one [15]. The licensed route is not collapsing, though: its 391 shipments in six months annualise to roughly 782, about four times the 191 logged for all of last year [18]. Both channels are growing. The unofficial one is compounding faster, at a first-half run rate of around 8,310 cases, seven times the 2025 figure [19].

The two sides of that ratio are not the same unit, and the difference cuts against the alarm. Customs is counting intercepted attempts on one side and consignments cleared by importers on the other. A licensed importer's shipment is wholesale volume; a seized international parcel is one person's month or two. Nine to one describes how many buyers are trying, not how many doses actually cross.

On price, sedaily puts a month's supply at about 150,000 won on foreign websites, with some listings at 70,000 to 100,000 won [5][6]. The cheap end sits 33 to 53 percent below the typical foreign figure [16], so buyers are not shopping against a single overseas price but against a spread. The domestic comparison in the report is the loose part: 150,000 won is described as, in some cases, more than half the price of a domestic prescription, which reads as a saving of more than half rather than a price above half [5]. Either reading leaves the gap large enough to move volume.

Everything caught at clearance is held and destroyed in full, with no partial quantity to fall back on [10], and the customs service treats unauthorised import as a Customs Act offence [11]. Each parcel is therefore a wager where the downside is the entire purchase. Cases multiplied anyway [1], which is a revealed estimate of the odds: buyers are acting as though the chance of interception, times the price paid, is still smaller than the domestic bill. The number that would test that belief is not in this dataset. Customs publishes catches, not attempts, so the pass-through rate is unknown to the agency and to the buyers alike.

Classification is what turns the price gap into a crime statistic. Ordinary medicines get a personal allowance of six bottles or a three-month supply [8]; these two get nothing at any quantity without a recommendation letter exempting them from import requirement verification [9]. There is no legal version of paying the foreign price, so the border absorbs the difference one mailbag at a time.

What to watch

  • Whether the Ministry of Food and Drug Safety revisits the harmful-drug designation or opens a limited personal-import allowance, which would pull volume back on-channel.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence68
Adoption
Insufficient
Hype gap+20
Incentives40
Confidence62
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    The Korea Customs Service said it caught 4,155 illegal imports of weight-loss drugs, including Mounjaro and Wegovy, in the first six months of this year, 3.5 times the 1,189 cases recorded for all of last year.

    ReportedSupportedSource: Korea Customs Service, via en.sedaily.com2 sources— create a free account to open themView cited source
  2. [2]

    Illegal import cases were four in 2024 and 1,189 last year, and topped 4,000 in the first half of this year; cumulative cases from 2024 through the first half of this year totalled 5,348.

  3. [3]

    Only 596 shipments cleared customs through licensed importers over the same period: 14 cases in 2024, 191 last year and 391 in the first half of this year.

Sources

1 independent publisher whose own reporting we read for this story.

  1. en.sedaily.com

    2 articles · August 24, 2026

    Illegal Imports of Weight-Loss Drugs Surge 3.5-Fold in Korea

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

  • Cross-border drug purchasingFollow
  • Drug pricing and reimbursementFollow
  • GLP-1 weight-loss drugsFollow

Entities

Loading related stories